Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids
The results identify several novel loci associated with plasma lipids that are also associated with CAD and provide the foundation to develop a broader biological understanding of lipoprotein metabolism and to identify new therapeutic opportunities for the prevention of CAD.
Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR, and these data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence.
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Revised formulas for summarizing retinal vessel diameters
- M. Knudtson, Kristine E. Lee, L. Hubbard, T. Wong, R. Klein, B. Klein
- MedicineCurrent Eye Research
- 1 January 2003
Revised formulas for summarizing retinal vessel diameters measured from fundus photographs are described, which offer the advantages of being more robust against variability in the number of vessels observed, being independent of image scale, and being easier to implement.
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050.
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis.
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
The results offer an explanation for the heterogeneity of TKI responses across individuals and suggest the possibility of personalizing therapy with BH3 mimetics to overcome BIM-polymorphism–associated TKI resistance.